886372-63-0 Usage
Uses
Used in Pharmaceutical Industry:
5-Fluoro-6-methoxy-pyridin-3-ylamine is used as an intermediate for the synthesis of various bioactive molecules and drugs. Its unique structure and functional groups make it a valuable component in the development of novel therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-Fluoro-6-methoxy-pyridin-3-ylamine may have potential applications in the design and synthesis of new drugs. Its presence of a fluorine atom and methoxy group can contribute to the modification of pharmacokinetic and pharmacodynamic properties of the resulting compounds.
Used in Organic Synthesis and Chemical Research:
5-Fluoro-6-methoxy-pyridin-3-ylamine may also be utilized as a building block or reagent in organic synthesis and chemical research. Its versatile structure allows for further functionalization and exploration of new chemical reactions, leading to the discovery of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 886372-63-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,7 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 886372-63:
(8*8)+(7*8)+(6*6)+(5*3)+(4*7)+(3*2)+(2*6)+(1*3)=220
220 % 10 = 0
So 886372-63-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H7FN2O/c1-10-6-5(7)2-4(8)3-9-6/h2-3H,8H2,1H3
886372-63-0Relevant articles and documents
COMPOUNDS USEFUL AS CSF1 MODULATORS
-
, (2016/04/26)
This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.